{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:13:26Z","timestamp":1791242006971,"version":"4.1.0"},"reference-count":212,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.vaccine.2008.01.029","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T13:23:55Z","timestamp":1202217835000},"page":"1501-1524","source":"Crossref","is-referenced-by-count":29,"title":["Mouse models for the study of mucosal vaccination against otitis media"],"prefix":"10.1016","volume":"26","author":[{"given":"Albert","family":"Sabirov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1567201043334588","article-title":"Mucosal immunisation: adjuvants and delivery systems","volume":"1","author":"Moyle","year":"2004","journal-title":"Curr Drug Deliv"},{"issue":"6 Pt 1","key":"10.1016\/j.vaccine.2008.01.029_bib2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1288\/00005537-199106000-00013","article-title":"Type B Haemophilus influenzae-induced otitis media in the mouse","volume":"101","author":"Krekorian","year":"1991","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1034\/j.1600-0463.2003.1111012.x","article-title":"A mouse model for acute otitis media","volume":"111","author":"Melhus","year":"2003","journal-title":"APMIS"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1288\/00005537-199506000-00013","article-title":"Expression of immunoregulatory cytokines during acute and chronic middle ear immune response","volume":"105","author":"Bikhazi","year":"1995","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00005537-199710000-00020","article-title":"Murine model of interleukin-8-induced otitis media","volume":"107","author":"Johnson","year":"1997","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"Ogra","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 11","key":"10.1016\/j.vaccine.2008.01.029_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0003489474083S1102","article-title":"Functional morphology of the lining membranes of the middle ear and Eustachian tube. An overview","volume":"83","author":"Lim","year":"1974","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archotol.1990.01870030088015","article-title":"Analysis of immunocompetent cells in the middle ear mucosa","volume":"116","author":"Ichimiya","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib9","first-page":"445","article-title":"Influenza vaccination in the prevention of acute otitis media in children","volume":"145","author":"Heikkinen","year":"1991","journal-title":"Am J Dis Child"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib10","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2165\/00003495-200262100-00002","article-title":"Prevention of otitis media by vaccination","volume":"62","author":"Russell","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2008.01.029_bib11","series-title":"Mucosal immunology","first-page":"1509","article-title":"Middle ear and eustachian tube","author":"Kurono","year":"2005"},{"issue":"17\/18","key":"10.1016\/j.vaccine.2008.01.029_bib12","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0264-410X(02)00768-5","article-title":"Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae","volume":"21","author":"Gu","year":"2003","journal-title":"Vaccine"},{"issue":"9512","key":"10.1016\/j.vaccine.2008.01.029_bib13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2008.01.029_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3928\/0090-4481-20021201-09","article-title":"Vaccination for the prevention of acute otitis media: proof of concept and current challenges","volume":"31","author":"Pelton","year":"2002","journal-title":"Pediatr Ann"},{"issue":"Suppl. 8","key":"10.1016\/j.vaccine.2008.01.029_bib15","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/00006454-200308001-00003","article-title":"Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine","volume":"22","author":"Harrison","year":"2003","journal-title":"Pediatr Infect J"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00006454-200004000-00036","article-title":"Efficacy of pneumococcal conjugate vaccines in large scale field trials","volume":"19","author":"Shinefield","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2008.01.029_bib17","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0264-410X(03)00206-8","article-title":"Mucosal immunization and adjuvants: a brief overview of recent advances and challenges","volume":"21","author":"Holmgren","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/088282403322396091","article-title":"Upper respiratory tract immunity","volume":"16","author":"Zuercher","year":"2003","journal-title":"Viral Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3201\/eid0602.000204","article-title":"Vaccines for mucosal immunity to combat emerging infectious diseases","volume":"6","author":"van Ginkel","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2008.01.029_bib21","series-title":"Mucosal immunology","first-page":"267","article-title":"Biological activities of IgA","author":"Russell","year":"2005"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2249.2003.02311.x","article-title":"Nasal-associated lymphoid tissue (NALT): frequency and localization in young children","volume":"134","author":"Debertin","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-5699(92)90158-4","article-title":"The role of nasopharyngeal lymphoid tissue","volume":"13","author":"Kuper","year":"1992","journal-title":"Immunol Today"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.01.029_bib25","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S0264-410X(00)00290-5","article-title":"Strategies of immunization against mucosal infections","volume":"19","author":"Russell","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib26","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.167.5.2441","article-title":"Cutting edge: dichotomy of homing receptor dependence by mucosal effector B cells: alpha(E) versus l-selectin","volume":"167","author":"Csencsits","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-A","article-title":"Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1","volume":"74","author":"Berlin","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2008.01.029_bib28","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.160.4.2000","article-title":"HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160","volume":"160","author":"VanCott","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib29","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/IAI.65.7.2676-2684.1997","article-title":"Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina","volume":"65","author":"Bergquist","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.01.029_bib30","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1128\/IAI.66.7.3390-3396.1998","article-title":"Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans","volume":"66","author":"Rudin","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.01.029_bib31","first-page":"33","article-title":"Dendritic cells and Langerhans cells in the uptake of mucosal antigens","volume":"236","author":"MacPherson","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nri1203","article-title":"Plasma-cell homing","volume":"3","author":"Kunkel","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib33","first-page":"257","article-title":"Design and delivery of non-parenteral vaccines","volume":"23","author":"Nugent","year":"1998","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.vaccine.2008.01.029_bib34","series-title":"Mucosal immunology","first-page":"855","article-title":"Mucosal vaccines: an overview","author":"Boyaka","year":"2005"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.162.1.122","article-title":"IL-12 is an effective adjuvant for induction of mucosal immunity","volume":"162","author":"Boyaka","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<256::AID-IMMU256>3.0.CO;2-G","article-title":"IL-12 is a potent neonatal vaccine adjuvant","volume":"29","author":"Arulanandam","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1988.tb00739.x","article-title":"The role of helper T cell products in mouse B cell differentiation and isotype regulation","volume":"102","author":"Coffman","year":"1988","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib38","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.4049\/jimmunol.162.6.3559","article-title":"Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production","volume":"162","author":"Yanagita","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(92)90021-B","article-title":"The mucosal immune system: from fundamental concepts to vaccine development","volume":"10","author":"McGhee","year":"1992","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib40","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3346::AID-IMMU3346>3.0.CO;2-P","article-title":"Nasal immune system: distinctive Th0 and Th1\/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively","volume":"28","author":"Hiroi","year":"1998","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2249.2001.01543.x","article-title":"Proliferating macrophages, dendritic cells, natural killer cells, T and B lymphocytes in the middle ear and Eustachian tube mucosa during experimental acute otitis media in the rat","volume":"126","author":"Jecker","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00175666","article-title":"Lymphocyte subsets in immune-mediated otitis media with effusion","volume":"249","author":"Takahashi","year":"1992","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.01.029_bib43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.vaccine.2005.07.110","article-title":"Eustachian tube possesses immunological characteristics as a mucosal effector site and responds to P6 outer membrane protein of nontypeable Haemophilus influenzae","volume":"24","author":"Kodama","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib44","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/IAI.68.4.2294-2300.2000","article-title":"Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization","volume":"68","author":"Kodama","year":"2000","journal-title":"Infect Immun"},{"issue":"27\/28","key":"10.1016\/j.vaccine.2008.01.029_bib45","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1016\/j.vaccine.2006.04.033","article-title":"Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media","volume":"24","author":"Sabirov","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.01.029_bib46","series-title":"Abstracts of the 9th international congress of mucosal immunology","first-page":"28","article-title":"Mucosal immune responses in mice immunized intranasally with outer membrane proteins of Haemophilus influenzae","author":"Kurono","year":"1997"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0264-410X(88)90140-5","article-title":"Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit","volume":"6","author":"Tamura","year":"1988","journal-title":"Vaccine"},{"issue":"4\/5","key":"10.1016\/j.vaccine.2008.01.029_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0264-410X(00)00208-5","article-title":"Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants","volume":"19","author":"McCluskie","year":"2000","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.01.029_bib49","first-page":"S45","article-title":"Animal models of otitis media: other pathogens","volume":"8","author":"Doyle","year":"1989","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/mdr.1999.5.57","article-title":"Otitis media: the chinchilla model","volume":"5","author":"Giebink","year":"1999","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.vaccine.2008.01.029_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3758\/BF03337511","article-title":"Nonsusceptibility to otitis media of the laboratory gerbil. Meriones unguiculatus","volume":"3","author":"Means","year":"1975","journal-title":"Physiol Psychol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib52","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.32.3.1113-1118.1981","article-title":"Indigenous nasopharyngeal, auditory canal, and middle ear bacterial flora of gerbils: animal model for otitis media","volume":"32","author":"Thompson","year":"1981","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005537-199702000-00012","article-title":"Hydrogen peroxide in acute otitis media in guinea pigs","volume":"107","author":"Takoudes","year":"1997","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib54","first-page":"325","article-title":"Cytotoxic changes in hair cells secondary to pneumococcal middle-ear infection","volume":"28","author":"Cook","year":"1999","journal-title":"J Otolaryngol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0385-8146(96)00022-3","article-title":"Experimental otitis media induced by nonviable Moraxella catarrhalis in the guinea pig model","volume":"24","author":"Sato","year":"1997","journal-title":"Auris Nasus Larynx"},{"issue":"8","key":"10.1016\/j.vaccine.2008.01.029_bib56","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archotol.1991.01870200083014","article-title":"Oral vaccine therapy for pneumococcal otitis media in an animal model","volume":"117","author":"Yoshimura","year":"1991","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib57","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/019459988609500406","article-title":"Otosurgical model in the guinea pig (Cavia porcellus)","volume":"95","author":"Wells","year":"1986","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2008.01.029_bib58","first-page":"276","article-title":"Otitis media in two strains of laboratory rats","volume":"11","author":"Daniel","year":"1971","journal-title":"J Aud Res"},{"key":"10.1016\/j.vaccine.2008.01.029_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3758\/BF03326857","article-title":"Otitis media in laboratory rats","volume":"1","author":"Daniel","year":"1973","journal-title":"Physiol Psychol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib60","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/IAI.69.5.2964-2971.2001","article-title":"Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media","volume":"69","author":"Sabirov","year":"2001","journal-title":"Infect Immun"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2008.01.029_bib61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0378-5955(99)00025-8","article-title":"The influence of pneumococcal otitis media on the cochlear lateral wall","volume":"131","author":"Ichimiya","year":"1999","journal-title":"Hear Res"},{"key":"10.1016\/j.vaccine.2008.01.029_bib62","series-title":"Committee on Infectious Diseases of Mice and Rats, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Infectious Diseases of Mice and Rats","year":"1991"},{"key":"10.1016\/j.vaccine.2008.01.029_bib63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000145527","article-title":"Anatomy of the rat middle ear. A study under the dissection microscope","volume":"112","author":"Hellmstrom","year":"1982","journal-title":"Acta Anat (Basel)"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/MMBR.62.2.294-308.1998","article-title":"Nontypeable Haemophilus influenzae: pathogenesis and prevention","volume":"62","author":"Foxwell","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2008.01.029_bib65","unstructured":"Westman E. Animal models for studies of middle ear pathology. In: Experimental acute otitis media. Aspects on treatment, protection and structural changes (Thesis, Umea University, Sweden). Sundsvall, Kaltes Grafiska AB; 2003. p. 19\u201320."},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2008.01.029_bib66","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/000348948209100118","article-title":"Comparative anatomy of eustachian tube and middle ear cavity in animal models for otitis media","volume":"91","author":"Daniel","year":"1982","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2006.01.046","article-title":"Mouse models as a tool to unravel the genetic basis for human otitis media","volume":"1091","author":"Zheng","year":"2006","journal-title":"Brain Res"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2008.01.029_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/000348940511401S01","article-title":"Recent advances in otitis media. 3. Animal models; anatomy and pathology; pathogenesis; cell biology and genetics","volume":"194","author":"Lim","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib69","series-title":"Handbook of mouse auditory research: from behavior to molecular biology","first-page":"505","article-title":"Mouse models for immunologic diseases of the auditory system","author":"Trune","year":"2001"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5955(92)90094-4","article-title":"Incidence of otitis media in CBA\/J and CBA\/CaJ mice","volume":"59","author":"McGinn","year":"1992","journal-title":"Hear Res"},{"issue":"7","key":"10.1016\/j.vaccine.2008.01.029_bib71","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1128\/IAI.72.7.4290-4292.2004","article-title":"Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant","volume":"72","author":"Malley","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib72","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1128\/IAI.72.10.5807-5813.2004","article-title":"Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization","volume":"72","author":"McCool","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib73","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1128\/IAI.71.10.5724-5732.2003","article-title":"Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization","volume":"71","author":"McCool","year":"2003","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainres.2006.02.004","article-title":"Mouse models of induced otitis media","volume":"1091","author":"Ryan","year":"2006","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1371\/journal.ppat.0030028","article-title":"Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae","volume":"3","author":"McCullers","year":"2007","journal-title":"PLoS Pathog"},{"issue":"12","key":"10.1016\/j.vaccine.2008.01.029_bib76","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.vaccine.2008.01.027","article-title":"Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue","volume":"26","author":"Sabirov","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.01.029_bib77","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1086\/382508","article-title":"Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae","volume":"189","author":"Bertot","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/000348949910800105","article-title":"Immunologic and histologic observations in reovirus-induced otitis media in the mouse","volume":"108","author":"Meek","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib79","series-title":"Abstracts of the 9th international symposium on recent advances in otitis media","first-page":"104","article-title":"Analysis of the cellular immune responses to influenza a virus infection in the middle ear","author":"Hirano","year":"2007"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib80","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0194-5998(99)70068-9","article-title":"Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization","volume":"121","author":"Hirano","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2008.01.029_bib81","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/infdis\/76.1.70","article-title":"Combined infection of mice with H. influenzae and influenza virus by the intranasal route","volume":"76","author":"Francis","year":"1945","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib82","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/341462","article-title":"Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor","volume":"186","author":"McCullers","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib83","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"McCullers","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib84","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1128\/JVI.79.10.6035-6042.2005","article-title":"Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus","volume":"79","author":"Gitiban","year":"2005","journal-title":"J Virol"},{"issue":"Suppl. 11","key":"10.1016\/j.vaccine.2008.01.029_bib85","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1097\/01.inf.0000144672.81955.a4","article-title":"Animal models for studying respiratory syncytial virus infection and its long term effects on lung function","volume":"23","author":"Domachowske","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2008.01.029_bib86","first-page":"1835","article-title":"Pathogenesis of Sendai virus infection in mice","volume":"32","author":"Appell","year":"1971","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib87","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rvsc.2006.03.009","article-title":"Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date","volume":"82","author":"Faisca","year":"2007","journal-title":"Res Vet Sci"},{"issue":"7","key":"10.1016\/j.vaccine.2008.01.029_bib88","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/01.mlg.0000224526.43698.52","article-title":"Persistent inflammation and hyperresponsiveness following viral rhinosinusitis","volume":"116","author":"Klemens","year":"2006","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1574-695X.2006.00186.x","article-title":"Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media","volume":"49","author":"Hirano","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib90","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.4049\/jimmunol.174.5.3006","article-title":"Identification of a peptide derived from vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signaling and reduces in vivo bacterial-induced inflammation","volume":"174","author":"McCoy","year":"2005","journal-title":"J Immunol"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2008.01.029_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.heares.2006.05.012","article-title":"Evaluation of the mouse model for acute otitis media","volume":"219","author":"MacArthur","year":"2006","journal-title":"Hear Res"},{"issue":"11","key":"10.1016\/j.vaccine.2008.01.029_bib92","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1128\/IAI.73.11.7718-7726.2005","article-title":"Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model","volume":"73","author":"van Rossum","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.01.029_bib93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1084\/jem.89.1.53","article-title":"Effect of the lesion due to influenza virus on the resistance of mice to inhaled pneumococci","volume":"89","author":"Harford","year":"1949","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib94","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mpat.1997.0142","article-title":"Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice","volume":"23","author":"Wu","year":"1997","journal-title":"Microb Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib95","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/IAI.73.10.6945-6951.2005","article-title":"Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci","volume":"73","author":"Briles","year":"2005","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2008.01.029_bib96","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.173.7.4576","article-title":"An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage","volume":"173","author":"Sun","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib97","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/IAI.69.4.2328-2338.2001","article-title":"(IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization","volume":"69","author":"Hodge","year":"2001","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib98","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/IAI.73.10.6892-6902.2005","article-title":"Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract","volume":"73","author":"van Ginkel","year":"2005","journal-title":"Infect Immun"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2008.01.029_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.heares.2007.05.011","article-title":"Tympanometry assessment of 61 inbred strains of mice","volume":"231","author":"Zheng","year":"2007","journal-title":"Hear Res"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib100","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","article-title":"Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines","volume":"168","author":"Asahi","year":"2002","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.01.029_bib101","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/IAI.71.8.4780-4788.2003","article-title":"Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12","volume":"71","author":"Lynch","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib102","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1128\/IAI.73.10.7043-7046.2005","article-title":"Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model","volume":"73","author":"Trzcinski","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.01.029_bib103","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib104","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/IAI.01972-06","article-title":"Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice","volume":"75","author":"Roche","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.01.029_bib105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10162-002-3015-9","article-title":"The deaf mouse mutant Jeff (Jf) is a single gene model of otitis media","volume":"4","author":"Hardistry","year":"2003","journal-title":"J Assoc Res Otolaryngol"},{"issue":"22","key":"10.1016\/j.vaccine.2008.01.029_bib106","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/hmg\/ddl403","article-title":"A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse","volume":"15","author":"Hardisty-Hughes","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib107","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1371\/journal.pgen.0020149","article-title":"Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media","volume":"2","author":"Parkinson","year":"2006","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib108","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-5876(02)00076-9","article-title":"Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae","volume":"65","author":"Hotomi","year":"2002","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib109","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.mlg.0000199740.04730.d4","article-title":"Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx","volume":"116","author":"Abe","year":"2006","journal-title":"Laryngoscope"},{"issue":"25\/26","key":"10.1016\/j.vaccine.2008.01.029_bib110","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1016\/j.vaccine.2004.02.027","article-title":"Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4\/rLP6\/UspA2 proteins combined with aqueous formulation of RC529","volume":"22","author":"Mason","year":"2004","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib111","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.vaccine.2004.08.042","article-title":"A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization","volume":"23","author":"Hotomi","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib112","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/344233","article-title":"Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice","volume":"186","author":"Cutter","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2003.tb00642.x","article-title":"Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx","volume":"35","author":"Hirano","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.01.029_bib114","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/IAI.69.8.4870-4873.2001","article-title":"Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci","volume":"69","author":"Malley","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.micinf.2005.10.020","article-title":"Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A","volume":"8","author":"Oliveira","year":"2006","journal-title":"Microbes Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib116","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/513980","article-title":"Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae","volume":"175","author":"Wu","year":"1997","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2008.01.029_bib117","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0264-410X(99)00511-3","article-title":"The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection","volume":"18","author":"Briles","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib118","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/IAI.68.2.796-800.2000","article-title":"Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae","volume":"68","author":"Briles","year":"2000","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2008.01.029_bib119","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1128\/IAI.69.11.6718-6724.2001","article-title":"Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection","volume":"69","author":"Arulanandam","year":"2001","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib120","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1128\/IAI.70.5.2526-2534.2002","article-title":"Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae","volume":"70","author":"Balachandran","year":"2002","journal-title":"Infect Immun"},{"issue":"14","key":"10.1016\/j.vaccine.2008.01.029_bib121","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.vaccine.2006.10.014","article-title":"Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in mice","volume":"25","author":"Tanaka","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib122","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/IAI.73.2.981-989.2005","article-title":"PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model","volume":"73","author":"Green","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib123","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1128\/IAI.69.6.3827-3836.2001","article-title":"Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge","volume":"69","author":"Zhang","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib124","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/IAI.74.4.2187-2195.2006","article-title":"Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide","volume":"74","author":"Malley","year":"2006","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib125","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1128\/JVI.65.4.2146-2148.1991","article-title":"Immunoglobulin A mediation of murine nasal anti-influenza virus immunity","volume":"65","author":"Renegar","year":"1991","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/eji.1830220228","article-title":"Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine","volume":"22","author":"Tamura","year":"1992","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib127","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4049\/jimmunol.149.3.981","article-title":"Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit","volume":"149","author":"Tamura","year":"1992","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib128","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0264-410X(94)90094-9","article-title":"Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice","volume":"12","author":"Tamura","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0264-410X(95)80002-U","article-title":"Cross-protection against influenza virus infection in mice vaccinated by combined nasal\/subcutaneous administration","volume":"13","author":"Asanuma","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0264-410X(90)90053-O","article-title":"Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination","volume":"8","author":"Hirabayashi","year":"1990","journal-title":"Vaccine"},{"issue":"29\/30","key":"10.1016\/j.vaccine.2008.01.029_bib131","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1016\/S0264-410X(02)00351-1","article-title":"Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K)","volume":"20","author":"Watanabe","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib132","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0264-410X(95)93129-W","article-title":"Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes","volume":"13","author":"de Haan","year":"1995","journal-title":"Vaccine"},{"issue":"20\u201322","key":"10.1016\/j.vaccine.2008.01.029_bib133","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/S0264-410X(00)00556-9","article-title":"Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity","volume":"19","author":"de Haan","year":"2001","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2008.01.029_bib134","first-page":"S2\/7","article-title":"The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery","volume":"24","author":"Davis","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/CDLI.12.1.171-179.2005","article-title":"Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus","volume":"12","author":"Valosky","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib136","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/infdis\/170.2.345","article-title":"Humoral, mucosal, and cellular immune response to topical immunization with a subunit respiratory syncytial virus vaccine","volume":"170","author":"Walsh","year":"1994","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2008.01.029_bib137","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0264-410X(94)90224-0","article-title":"Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit","volume":"12","author":"Oien","year":"1994","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.029_bib138","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.4049\/jimmunol.139.10.3484","article-title":"Combined oral\/nasal immunization protects mice from Sendai virus infection","volume":"139","author":"Nedrud","year":"1987","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib139","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/JVI.71.1.832-838.1997","article-title":"Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses","volume":"71","author":"Takao","year":"1997","journal-title":"J Virol"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2008.01.029_bib140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2008.01.029_bib141","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/00034894051140S110","article-title":"Recent advances in otitis media. 6. Vaccine","volume":"194","author":"Giebink","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib142","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0003489492101S1004","article-title":"Inhibition of nasopharyngeal colonization of Haemophilus influenzae by oral immunization","volume":"157","author":"Kurono","year":"1992","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5 Pt 1","key":"10.1016\/j.vaccine.2008.01.029_bib143","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00005537-199605000-00018","article-title":"Effects of oral and systemic immunization on nasopharyngeal clearance of nontypeable Haemophilus influenzae in BALB\/c mice","volume":"106","author":"Kurono","year":"1996","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib144","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/00016489850182594","article-title":"Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins","volume":"118","author":"Suzuki","year":"1998","journal-title":"Acta Otolaryngol"},{"issue":"20","key":"10.1016\/j.vaccine.2008.01.029_bib145","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0264-410X(98)00122-4","article-title":"Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin","volume":"16","author":"Hotomi","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib146","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/314827","article-title":"Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity","volume":"180","author":"Kurono","year":"1999","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib147","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2006.08.005","article-title":"Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine","volume":"107","author":"Hirano","year":"2006","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib148","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.mlg.0000194222.93067.f7","article-title":"Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant","volume":"116","author":"Kodama","year":"2006","journal-title":"Laryngoscope"},{"issue":"25","key":"10.1016\/j.vaccine.2008.01.029_bib149","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1016\/j.vaccine.2006.03.056","article-title":"Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring","volume":"24","author":"Yamauchi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.01.029_bib150","series-title":"Abstracts of the 9th international symposium on recent advances in otitis media","first-page":"71","article-title":"A single nasal dose of Flt3 ligand enhances mucosal immune responses in the nasopharynx","author":"Kodama","year":"2007"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib151","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.inf.0000125892.66941.a9","article-title":"Rationale and prospects for a nontypeable Haemophilus influenzae vaccine","volume":"23","author":"Barenkamp","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.01.029_bib152","series-title":"Abstracts of the 9th international symposium on recent advances in otitis media","first-page":"112","article-title":"Protection of pneumococcal infection by maternal immunization with pneumococcal surface protein a (PspA)","author":"Katsurahara","year":"2007"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib153","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10408410600822942","article-title":"Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies","volume":"32","author":"Tai","year":"2006","journal-title":"Crit Rev Microbiol"},{"issue":"17\/18","key":"10.1016\/j.vaccine.2008.01.029_bib154","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/S0264-410X(02)00097-X","article-title":"A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model","volume":"20","author":"Hou","year":"2002","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.01.029_bib155","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1128\/IAI.70.11.5982-5989.2002","article-title":"Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine","volume":"70","author":"Jiao","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib156","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-3083.1988.tb02343.x","article-title":"The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes","volume":"27","author":"L\u00f6vgren","year":"1988","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib157","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2249.1990.tb05467.x","article-title":"An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration","volume":"82","author":"L\u00f6vgren","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib158","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000234695","article-title":"Enhanced murine respiratory tract IgA antibody response to oral influenza vaccine when combined with a lipoidal amine (avridine)","volume":"87","author":"Bergmann","year":"1988","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib159","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0264-410X(89)90055-8","article-title":"Intranasal immunization with proteoliposomes protects against influenza","volume":"7","author":"el Guink","year":"1989","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/infdis\/167.1.84","article-title":"Oral immunization with influenza virus in biodegradable microspheres","volume":"167","author":"Moldoveanu","year":"1993","journal-title":"J Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2008.01.029_bib161","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/0264-410X(93)90099-J","article-title":"Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice","volume":"11","author":"Ben Ahmeida","year":"1993","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib162","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0264-410X(94)90118-X","article-title":"Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine","volume":"12","author":"Tamura","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib163","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.162.5.2530","article-title":"Mucosal immunity to influenza without IgA: an IgA knockout mouse model","volume":"162","author":"Mbawuike","year":"1999","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib164","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.0019-2805.2001.01368.x","article-title":"Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus","volume":"105","author":"Zhang","year":"2002","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jmv.1890320112","article-title":"Rapid recovery in mice after combined nasal\/oral immunization with killed respiratory syncytial virus","volume":"32","author":"Reuman","year":"1990","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib166","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0264-410X(92)90026-G","article-title":"Initiation of cytotoxic T-cell response and protection of Balb\/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine","volume":"10","author":"Trudel","year":"1992","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib167","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.micpath.2003.10.007","article-title":"Regional differences in the early mucosal immune response induced by primary inoculation of mice with respiratory syncytial virus","volume":"36","author":"Hishiki","year":"2004","journal-title":"Microb Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib168","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/eji.200535493","article-title":"Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge","volume":"36","author":"Etchart","year":"2006","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib169","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2249.1998.00650.x","article-title":"The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses","volume":"113","author":"Hu","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"7\/8","key":"10.1016\/j.vaccine.2008.01.029_bib170","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0264-410X(98)00267-9","article-title":"Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines","volume":"17","author":"Bastien","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.01.029_bib171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/vim.1999.12.41","article-title":"A novel and effective intranasal immunization strategy for respiratory syncytial virus","volume":"12","author":"Tebbey","year":"1999","journal-title":"Viral Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2008.01.029_bib172","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/S0264-410X(00)00058-X","article-title":"Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H","volume":"18","author":"Tebbey","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib173","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF02977620","article-title":"Intranasal vaccination with peptides and cholera toxin subunit B as adjuvant to enhance mucosal and systemic immunity to respiratory syncytial virus","volume":"30","author":"Kim","year":"2007","journal-title":"Arch Pharm Res"},{"issue":"29","key":"10.1016\/j.vaccine.2008.01.029_bib174","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1016\/j.vaccine.2007.05.004","article-title":"Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB\/c mice against challenge without eosinophilia or enhanced pathology","volume":"25","author":"Cyr","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/viro.1994.1665","article-title":"Age-related development of human memory T-helper and B-cell responses toward parainfluenza virus type-1","volume":"205","author":"Smith","year":"1994","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib176","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/viro.1995.1448","article-title":"Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection","volume":"212","author":"Sangster","year":"1995","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.vaccine.2008.01.029_bib177","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/89775","article-title":"IgA production without mu or delta chain expression in developing B cells","volume":"2","author":"Macpherson","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib178","series-title":"Mucosal immunology","first-page":"855","article-title":"Mucosal vaccines: an overview","author":"Boyaka","year":"2005"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib179","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4049\/jimmunol.141.5.1495","article-title":"Oral administration of cholera toxin\u2013Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus","volume":"141","author":"Liang","year":"1988","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.01.029_bib180","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/IAI.67.11.5892-5897.1999","article-title":"Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections","volume":"67","author":"Jakobsen","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib181","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/713608018","article-title":"Protective immunity of pneumococcal glycoconjugates","volume":"29","author":"Lee","year":"2003","journal-title":"Crit Rev Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib182","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1086\/338928","article-title":"Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a","volume":"185","author":"Johnson","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.01.029_bib183","series-title":"Mucosal immunology","first-page":"485","article-title":"Mucosal immune responses: an overview","author":"McGhee","year":"1999"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib184","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines","volume":"58","author":"Tamura","year":"2005","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib185","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J Immunol"},{"issue":"17\/18","key":"10.1016\/j.vaccine.2008.01.029_bib186","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0264-410X(96)00128-4","article-title":"Antibody responses and protection in mice immunized orally against influenza virus","volume":"14","author":"Takase","year":"1996","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib187","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/eji.1830210602","article-title":"Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules","volume":"21","author":"Tamura","year":"1991","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.01.029_bib188","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/AAC.38.12.2785","article-title":"Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice","volume":"38","author":"Weltzin","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib189","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/07853890109002074","article-title":"Mucosal immunity and viral infections","volume":"33","author":"Freihorst","year":"2001","journal-title":"Ann Med"},{"issue":"12","key":"10.1016\/j.vaccine.2008.01.029_bib190","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.029_bib191","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/vim.2005.18.255","article-title":"Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus","volume":"18","author":"Takimoto","year":"2005","journal-title":"Viral Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.01.029_bib192","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1128\/JVI.78.11.6043-6047.2004","article-title":"Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV","volume":"78","author":"Takimoto","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib193","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-065X.1997.tb01010.x","article-title":"Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections","volume":"159","author":"Doherty","year":"1997","journal-title":"Immunol Rev"},{"issue":"50","key":"10.1016\/j.vaccine.2008.01.029_bib194","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2005.07.046","article-title":"A review of vaccine research and development: human acute respiratory infections","volume":"23","author":"Girard","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib195","first-page":"375","article-title":"Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells","volume":"67","author":"Mackenzie","year":"1989","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib196","first-page":"139","article-title":"Do L3T4+ T cells act as effector cells in protection against influenza virus infection","volume":"62","author":"Lightman","year":"1987","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib197","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/jimmunol.160.1.322","article-title":"Mechanism of protective immunity against influenza virus infection in mice without antibodies","volume":"160","author":"Epstein","year":"1998","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.01.029_bib198","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.4049\/jimmunol.166.12.7437","article-title":"Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells","volume":"166","author":"Benton","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.01.029_bib199","series-title":"Mucosal immune defense: immunoglobulin","first-page":"269","article-title":"IgA and respiratory immunity","author":"Metzger","year":"2007"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib200","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00006454-198607000-00011","article-title":"Antibody response of young children to parenteral vaccination with pneumococcal capsular polysaccharides: a comparison between antibody levels in serum and middle ear effusion","volume":"5","author":"Koskela","year":"1986","journal-title":"Pediatr Infect Dis"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2008.01.029_bib201","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-3659(99)00231-X","article-title":"Oral vaccine delivery","volume":"65","author":"Russell-Jones","year":"2000","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib202","first-page":"169","article-title":"Epicutaneous and transcutaneous immunization using DNA or proteins","volume":"9","author":"Kaiserlian","year":"1999","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S1466252300000025","article-title":"Mechanisms of vaccine adjuvanticity at mucosal surfaces","volume":"1","author":"Foss","year":"2000","journal-title":"Anim Health Res Rev"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2008.01.029_bib204","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.029_bib205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10408410591005093","article-title":"Mucosal immunity induced by pneumococcal glycoconjugate","volume":"31","author":"Lee","year":"2005","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib206","first-page":"17","article-title":"Lactic acid bacteria as live vaccines","volume":"2","author":"Mercenier","year":"2000","journal-title":"Curr Issues Mol Biol"},{"issue":"25\/26","key":"10.1016\/j.vaccine.2008.01.029_bib207","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib208","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1586\/14760584.4.6.843","article-title":"Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges","volume":"4","author":"Murphy","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2008.01.029_bib209","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ni1343","article-title":"Influenza and the challenge for immunology","volume":"7","author":"Doherty","year":"2006","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.029_bib210","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/IAI.01716-06","article-title":"Modulation of adherence, invasion, and tumor necrosis factor alpha secretion during the early stages of infection by Streptococcus pneumoniae ClpL","volume":"75","author":"Tu Le","year":"2007","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.029_bib211","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/17425247.4.4.323","article-title":"Oral vaccination: where we are?","volume":"4","author":"Silin","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.029_bib212","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2006.01.002","article-title":"Mucosal delivery of vaccine antigens and its advantages in pediatrics","volume":"58","author":"De Magistris","year":"2006","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T23:02:15Z","timestamp":1708556535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":212,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0264410X08000728"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.01.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}